Advertisements



We are Sorry, This Page doesn't Exist


Gilead announces findings from a new analysis of the ZUMA-1 trial of Yescarta

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 10th, 2021

Harborside Inc. Announces Preliminary Fiscal 2019 and First Quarter 2020 Results and Advises on Timing of Filing Annual Financial Statements and Management"s Discussion and Analysis

-       Preliminary Fiscal 2019 Results Consistent with Previously Announced Full Year Guidance-       Strong Start to Fiscal 2020 Based on Preliminary First Quarter 2020 Interim Results-       Earnings for F.....»»

Category: earningsSource: benzingaApr 23rd, 2020

Kadmon announces expanded results of interim analysis of KD025 trial in cGVHD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2020

Immunic announces results of interim dosing analysis for CALDOSE-1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019

Array BioPharma announces interim analysis results from BEACON CRC trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 7th, 2019

AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 16th, 2019

La Jolla announces results from interim analysis of Phase 2 study of LJPC-401

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2019

Rubicon Minerals Announces the Filing of its First Quarter 2019 Results

TSX: RMX | OTCQX: RBYCF TORONTO, May 8, 2019 /CNW/ - Rubicon Minerals Corporation (TSX:RMX, OTCQX:RBYCF) ("Rubicon" or the "Company") announces that it has filed its interim Financial Statements and Management's Discussion and Analysis ("MD&A").....»»

Category: earningsSource: benzingaMay 8th, 2019

Alnylam announces "positive" topline results form interim analysis of ENVISION

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 27th, 2018

Partners Value Investments Inc. Announces Q1 2021 Interim Results

TORON.....»»

Category: earningsSource: benzingaMay 23rd, 2021

SQI Diagnostics Reports Second Quarter 2021 Results and Announces Departure of CEO and Appointment of Interim CEO

TORONTO, May 21, 2021 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV:SQD) (OTCQB:SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare pr.....»»

Category: earningsSource: benzingaMay 23rd, 2021

SQI Diagnostics Reports Second Quarter 2021 Results and Announces Departure of CEO and Appointment of Interim CEO

TORONTO, May 21, 2021 /CNW/ - SQI Diagnost.....»»

Category: earningsSource: benzingaMay 23rd, 2021

Genentech announces interim results from Phase III IMpower010 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 19th, 2021

Treace Medical announces interim results from ALIGN3D study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 19th, 2021

ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update

Interim futility analysis from the Phase 3 DISRUPT study of exebacase evaluating treatment superiority is anticipated in H2 2021 BARDA contract award provides up to $86.8 million for exebacase development Strong fi.....»»

Category: earningsSource: benzingaMay 14th, 2021

iCAD announces results from ProFound AI retrospective analysis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 31st, 2021

VBL Therapeutics announces publication of interim analysis of OVAL study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 4th, 2021

Galapagos announces interim results from MANTA, MANTA-RAy studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 4th, 2021

Benitec Biopharma reports results from interim analysis of BB-301 dosing study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 24th, 2021

Puma Biotechnology announces interim results from SUMMIT trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 15th, 2021